🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ming Zhao

Academy of Medical Sciences

ORCID: 0000-0002-1320-1093

Also affiliated with Central South University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, SKiN Health, Chinese Academy of Medical Sciences Dermatology Hospital, Institute of Dermatology, Women's Hospital, School of Medicine, Zhejiang University, Second Xiangya Hospital of Central South University, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Epigenomics (Germany)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients”.

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

Clinical Immunology(2020)10.1016/j.clim.2020.108410
N/A
9.6DataRank · unranked
271 citations

Ming Zhao, Patrick Coit, Qianjin Lu, Amr H. Sawalha

Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma

Journal of Hepatology(2023)10.1016/j.jhep.2023.10.041
N/A
1.0DataRank · unranked
36 citations

Ming Zhao, Kurt W. Evans, Kaushik Varadarajan, Tyler Moss, Stephen Scott +12 more

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan

npj Breast Cancer(2023)10.1038/s41523-023-00573-8
N/A
0.524DataRank · unranked
32 citations

Timothy P. DiPeri, Maria Gabriela Raso, Xiaofeng Zheng, Yasmeen Qamar Rizvi, Kurt W. Evans +8 more

Antitumor Activity and Biomarker Analysis for TROP2 Antibody–Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1948
N/A
0.470DataRank · unranked
22 citations

Erkan Yuca, Kurt W. Evans, Ming Zhao, Takanori Maejima, Tsuyoshi Karibe +12 more

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

Research Square(2022)10.21203/rs.3.rs-2248209/v1
N/A
0DataRank · unranked
0 citations

Turçin Saridogan, Argun Akçakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca +11 more

Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0103
N/A
0DataRank · unranked
29 citations

Kurt W. Evans, Maria Gabriela Raso, Ming Zhao, Yasmeen Q. Rizvi, Xiaofeng Zheng +11 more

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

Scientific Reports(2023)10.1038/s41598-023-46586-y
N/A
0DataRank · unranked
15 citations

Argun Akçakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca, Stephen Scott +11 more

Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0838
N/A
0DataRank · unranked
25 citations

Kurt W. Evans, Bailiang Wang, Ming Zhao, Argun Akçakanat, Maria Gabriela Raso +14 more

Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1233
N/A
0DataRank · unranked
1 citations

Kurt W. Evans, Stephen Scott, Xiaofeng Zheng, Kaushik Varadarajan, Lawrence N. Kwong +16 more

Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0884
N/A
0DataRank · unranked
1 citations

Christian X. Cruz Pico, Kurt W. Evans, Maria Gabriela Raso, Yasmeen Q. Rizvi, Xiaofeng Zheng +10 more

TGF-β and Eomes control the homeostasis of CD8+ regulatory T cells

The Journal of Experimental Medicine(2020)10.1084/jem.20200030
N/A
0DataRank · unranked
66 citations

Wei Liao, Yong Liu, Ming Yang, Chaoyu Ma, Haijing Wu +6 more

The downregulation of IL-18R defines bona fide kidney-resident CD8+ T cells

iScience(2021)10.1016/j.isci.2020.101975
N/A
0DataRank · unranked
18 citations

Yong Liu, Chaoyu Ma, Liwen Wang, Guo Li, Shruti Mishra +12 more

Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations

Scientific Reports(2022)10.1038/s41598-022-05193-z
N/A
0DataRank · unranked
9 citations

Argun Akçakanat, Scott Kopetz, Coya Tapia, Xiaofeng Zheng, Huiqin Chen +12 more